NCT01583452

Brief Summary

Post- operative ileus refers to the time after surgery before coordinated electromotor bowel function resumes. It's treatment and prevention may signify an elevated hospitalization cost and the exposure to the patient to adverse effects of drugs. The current clinical trial has as primary objective to prove the efficacy of chewing gum as a preventive measure of post-operative ileus in pediatric patients after gastrointestinal surgery through the determination of the time the patient takes to tolerate oral intake, pass flatus, present bowel movements and the time of hospital stay. Patients will be assigned either to the case group (chewing gum + standard treatment) or to the control group (standard treatment), in both of them time from the end of surgery to the moment the patient presents first bowel movement, passes flatus, tolerates oral intake (any type of food) and is discharged from hospital; will be measured in hours and then analyzed to determine the validity of these data.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Apr 2012

Shorter than P25 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 3, 2012

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 24, 2012

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2012

Completed
2.9 years until next milestone

Results Posted

Study results publicly available

July 23, 2015

Completed
Last Updated

July 23, 2015

Status Verified

June 1, 2015

Enrollment Period

4 months

First QC Date

April 3, 2012

Results QC Date

March 19, 2015

Last Update Submit

June 27, 2015

Conditions

Keywords

Post operative ileusGastrointestinal surgeryChewing gum

Outcome Measures

Primary Outcomes (1)

  • Post-Operative Hospital Stay

    The time between the end of surgery and hospital discharge, measured in hours

    End of surgery to hospital discharge (from 4 to 7 days)

Secondary Outcomes (3)

  • Time to First Flatus

    End of surgery to first flatus (from 1 to 3 days)

  • Time to First Bowel Movement

    End of surgery to first bowel motion (from 1 to 7 days)

  • Time to Tolerate Feedings (Oral Intake)

    End of surgery to oral intake tolerance (from 1 to 3 days)

Study Arms (2)

Chewing Gum Group

EXPERIMENTAL

Group of patients given chewing gum as part of the treatment for prevention of post-operative ileus right after surgery, besides the standard pharmacologic treatment and post-operative care.

Other: Chewing Gum

No intervention

NO INTERVENTION

By observing the clinical evolution of the participants not given chewing gum as a prevention for post-operative ileus, and just given the standard pharmacologic treatment and post-operative care.

Interventions

The use of chewing gum as a preventive measure for post-operative ileus

Also known as: Sugarless chewing gum, Trident, Orbit, Ice Breakers, Smint
Chewing Gum Group

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Pediatric patients who underwent any type of gastrointestinal surgery.

You may not qualify if:

  • Patients unable to chew
  • Patients unable to swallow
  • Patients whose clinical status is critical
  • Patients with gastrointestinal motility disorders not associated with GI surgeries.
  • Patients unable to follow directions about the use of chewing gum

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital San Jose Tec de Monterrey

Monterrey, Nuevo León, 64710, Mexico

Location

Related Publications (6)

  • Vasquez W, Hernandez AV, Garcia-Sabrido JL. Is gum chewing useful for ileus after elective colorectal surgery? A systematic review and meta-analysis of randomized clinical trials. J Gastrointest Surg. 2009 Apr;13(4):649-56. doi: 10.1007/s11605-008-0756-8. Epub 2008 Dec 3.

    PMID: 19050983BACKGROUND
  • Johnson MD, Walsh RM. Current therapies to shorten postoperative ileus. Cleve Clin J Med. 2009 Nov;76(11):641-8. doi: 10.3949/ccjm.76a.09051.

    PMID: 19884293BACKGROUND
  • Purkayastha S, Tilney HS, Darzi AW, Tekkis PP. Meta-analysis of randomized studies evaluating chewing gum to enhance postoperative recovery following colectomy. Arch Surg. 2008 Aug;143(8):788-93. doi: 10.1001/archsurg.143.8.788.

    PMID: 18711040BACKGROUND
  • de Castro SM, van den Esschert JW, van Heek NT, Dalhuisen S, Koelemay MJ, Busch OR, Gouma DJ. A systematic review of the efficacy of gum chewing for the amelioration of postoperative ileus. Dig Surg. 2008;25(1):39-45. doi: 10.1159/000117822. Epub 2008 Feb 21.

    PMID: 18292660BACKGROUND
  • Noble EJ, Harris R, Hosie KB, Thomas S, Lewis SJ. Gum chewing reduces postoperative ileus? A systematic review and meta-analysis. Int J Surg. 2009 Apr;7(2):100-5. doi: 10.1016/j.ijsu.2009.01.006. Epub 2009 Jan 31.

    PMID: 19261555BACKGROUND
  • Fitzgerald JE, Ahmed I. Systematic review and meta-analysis of chewing-gum therapy in the reduction of postoperative paralytic ileus following gastrointestinal surgery. World J Surg. 2009 Dec;33(12):2557-66. doi: 10.1007/s00268-009-0104-5.

    PMID: 19763686BACKGROUND

MeSH Terms

Interventions

Chewing GumForkhead Box Protein M1

Intervention Hierarchy (Ancestors)

Plant GumsBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesPlant ExudatesBiological ProductsComplex MixturesCandyFoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesForkhead Transcription FactorsWinged-Helix Transcription FactorsDNA-Binding ProteinsProteinsAmino Acids, Peptides, and ProteinsTranscription Factors

Limitations and Caveats

We had a small number of participants because of time limitations. We included only patients with diagnosis of appendicitis and post-op appendectomy.

Results Point of Contact

Title
Gabriela López Jaimez
Organization
ITESM - Pediatrics Division

Study Officials

  • Gabriela Lopez, MD

    Instituto Tecnologico y de Estudios Superiores de Monterey

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Pediatrics Resident

Study Record Dates

First Submitted

April 3, 2012

First Posted

April 24, 2012

Study Start

April 1, 2012

Primary Completion

August 1, 2012

Study Completion

September 1, 2012

Last Updated

July 23, 2015

Results First Posted

July 23, 2015

Record last verified: 2015-06

Locations